# Attovia Therapeutics Posts Third-Quarter GAAP Loss of $0.76 Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54185
Published: 2026-11-11T16:00:03.000Z
Updated: 2026-11-11T16:00:03.000Z
Section: Business

> The figure covered the three months ended Sept. 30, 2026, on both basic and diluted bases.

Attovia Therapeutics, Inc. recorded a GAAP net loss of $0.76 per share for the third quarter of 2026, reporting its per-share result for the period ended Sept. 30.

The figure was the net loss per share attributable to common stockholders on both a basic and diluted basis. The financial statements were prepared under U.S. generally accepted accounting principles.